Tag: drug discovery
Mayo Clinic AI finds drug path to ‘undruggable’ cancer protein
AI screening of nearly 40,000 compounds produced a GIPC1 inhibitor that slowed pancreatic tumor growth in preclinical models.
AWS becomes Novo Nordisk’s preferred AI partner for drug discovery
Novo Nordisk names AWS its preferred cloud and AI partner, opening a London hub to speed drug discovery.
Merck confirms drug design from Stanford’s 37,000-agent virtual biotech
Stanford's virtual biotech of 37,000 AI agents designed a lung cancer drug that Merck later validated.
OpenAI bets on academia with free frontier AI for 100,000 scientists
OpenAI will give up to 100,000 academic researchers free access to frontier models, including 75-plus life-science tools for genomics and…
AI-focused venture firm Dimension restocks with $800M third fund
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing and life sciences.
NIH commits to $5B Genesis Mission for biomedical AI research
HHS commits NIH resources to Trump's $5B Genesis Mission, targeting chronic disease, pediatric cancer, and drug discovery through AI.
Doudna Lab uses AI to design novel gene-editing enzymes from scratch
Nobel laureate Jennifer Doudna's team uses inverse protein folding AI to create never-before-seen genome editing enzymes.
Insilico and Bora Pharma bring generative AI to drug manufacturing
The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.